Leading voices confirmed include:
George Paraskevakos, Executive Director, IPA (International Probiotics Association)
Elaine Patterson, Senior Scientist and Technical Lead of the Brain Health Platform at DuPont Nutrition & Biosciences.
Udo Herz, Medical and Science Director at Danone Nutricia Specialized Nutrition
Daniel Ramón Vidal, PhD, Vice President, R&D Health & Wellness at ADM
Dr Zain M Saiyed, Associate Director, R&D, Ingredients Innovation, Lonza Capsules & Health Ingredients
Dr Luis Gosalbez, Managing Director and co-founder at Sandwalk Bioventures
Dr Orla O’Sullivan, Senior Research Officer at Teagasc Food Research Centre
Dr Vanessa Stadlbauer, Clinical gastroenterologist & hepatologist and associate professor at the Medical University of Graz
Leading voices confirmed include:
George Paraskevakos, Executive Director, IPA (International Probiotics Association)
Elaine Patterson, Senior Scientist and Technical Lead of the Brain Health Platform at DuPont Nutrition & Biosciences.
Udo Herz, Medical and Science Director at Danone Nutricia Specialized Nutrition
Daniel Ramón Vidal, PhD, Vice President, R&D Health & Wellness at ADM
Dr Zain M Saiyed, Associate Director, R&D, Ingredients Innovation, Lonza Capsules & Health Ingredients
Dr Luis Gosalbez, Managing Director and co-founder at Sandwalk Bioventures
Dr Orla O’Sullivan, Senior Research Officer at Teagasc Food Research Centre
Dr Vanessa Stadlbauer, Clinical gastroenterologist & hepatologist and associate professor at the Medical University of Graz
The International Probiotics Association (IPA) has weighed in on Spain’s recent decision to permit probiotic labelling despite an EU ban, saying an international standard could resolve Europe’s increasingly splintered probiotics position.
“The establishment of global requirements would satisfy the triumvirate of authorities, consumers and, industry and will certainly lead to quality products, better consumer satisfaction, and health and well-being,” IPA executive director, George Paraskevakos told NutraIngredients.
Spain’s
recent decision to use EU mutual recognition principles to allow the term ‘probiotic’ on-product despite an EU ban on probiotics as an unauthorised health claim, has provoked law experts to question how much longer the EU ban can last.
The International Probiotics Association (IPA) has weighed in on Spain’s recent decision to permit probiotic labelling despite an EU ban, saying an international standard could resolve Europe’s increasingly splintered probiotics position.
“The establishment of global requirements would satisfy the triumvirate of authorities, consumers and, industry and will certainly lead to quality products, better consumer satisfaction, and health and well-being,” IPA executive director, George Paraskevakos told NutraIngredients.
Spain’s
recent decision to use EU mutual recognition principles to allow the term ‘probiotic’ on-product despite an EU ban on probiotics as an unauthorised health claim, has provoked law experts to question how much longer the EU ban can last.
India’s probiotic controversy: Industry questions methodology used by researchers who criticised label claims A study that claims that commercial probiotics sold in India are not true to label claims has come under fire for the methodologies used.
The study, involving researchers from Apollo Children’s Hospital in Chennai, Madras Medical Mission, and NITTE University, was published on the journal
Cureus last month.
It claimed that there was
“very poor correlation” between the declared contents on the pack and lab values in viable cell count colonies, the genus and species strain identification, and contaminants were detected.
The paper has since attracted significant attention from the industry in India, especially for the test protocol used.